Clinical Trials
2 trialsNCT06624371 2025-07-22
AflacBT2303
Emory University
Phase 1 Recruiting
NCT00360854 2013-09-20
Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma
National Cancer Institute (NCI)
Phase 1 Unknown